Package Leaflet: Information for the User
Selexid 400 mg film-coated tabletsEFG
Pivmecillinam hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Selexid belongs to a group of medicines called penicillins. It is a type of antibiotic. Selexid works by killing the bacteria that cause infections.
Antibiotics are used to treat bacterial infections and are not effective against viral infections. It is important that you follow the instructions regarding the dose, administration interval, and treatment duration indicated by your doctor. Do not store or reuse this medicine. If you have any leftover antibiotic after finishing the treatment, return it to the pharmacy for proper disposal. Do not throw away medicines via wastewater or household waste. |
Selexid is used to treat bladder infections (cystitis) in adults.
Do not take Selexid:
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Selexid. The tablets should be taken with at least half a glass of liquid to avoid the tablets getting stuck in the digestive tract.
Before starting treatment, inform your doctor:
During treatment:
Children and adolescents
Do not give this medicine to children and adolescents under 18 years of age, as the potential benefits may not outweigh the risks.
Taking Selexid with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Inform your doctor or pharmacist if you are taking any of the following medicines:
This may affect the effect of Selexid.
Taking Selexid with food and drinks
You can take the medicine with or immediately after a meal. Selexid should be taken with at least half a glass of water. It is important that you take your medicine with plenty of liquid and a long time before going to bed. This will prevent digestive tract disorders.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Selexid can be used during pregnancy.
There have been reports of false positives in neonatal screening tests, where it has simulated the presence of isovaleric acidemia. Taking pivmecillinam shortly before birth may affect the results of neonatal tests for detecting hereditary metabolic disorders and give a false positive result. A "false positive" means that the result incorrectly indicates that the baby has a disorder. There is no risk to the neonate, but you should inform your doctor that you have taken Selexid shortly before birth.
Breastfeeding
Selexid can be used during breastfeeding.
Fertility
No clinical studies have been conducted regarding fertility.
Driving and using machines
The influence of Selexid on the ability to drive and use machines is negligible.
The recommended dose is 400 mg 3 times a day.
Elderly patients: No dose adjustment is necessary.
In case of renal or hepatic insufficiency, no dose adjustment is necessary.
If you take more Selexid than you should
Inform your doctor immediately. You may need to stop taking this medicine. You may feel nauseous, vomit, or have stomach disorders.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Selexid
If you forget to take the medicine, take it as soon as you remember. You should take it with at least half a glass of water or other liquid. Then, take the next dose at the usual time.
If you stop taking Selexid
It is very important that you take all the medicine that your doctor has indicated. You should finish this medicine even if you feel better, otherwise, you may become ill again.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects:
Stop treatment with Selexid and seek immediate medical attention if you notice any of the following symptoms:
Anaphylactic reactions and Clostridium difficile colitis are rare and may affect up to 1 in 100 people. The occurrence of angioedema and anaphylactic shock is unknown.
Contact your doctor if you notice the following seriousside effects:
Other side effects:
Frequent (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that the side effects are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System: https://www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month stated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Selexid
Appearance and packaging of the product
Selexid is a white, capsule-shaped, film-coated tablet, 8 x 17 mm in size.
Pack sizes:
9, 10, 15, and 20 tablets in blisters.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Karo Pharma AB
Box 16184
103 24 Stockholm
Sweden
Manufacturer:
Recipharm Strängnäs AB, Mariefredsvägen 35, S-645 41 Strängnäs, Sweden
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder:
Laboratorios Gebro Pharma, S.A.
Avenida Tibidabo n° 29
08022 Barcelona
Spain
Phone: +34 93 205 86 86
This medicine is authorized in the Member States of the European Economic Area under the following names:
Belgium: Selexid® 400 mg Tabletten
Denmark: Pivmecillinamhydrochlorid Karo Pharma
Netherlands: Selexid® 400 mg Filmomhulde tabletten
Ireland: Pivmecillinam hydrochloride Karo Pharma 400 mg film-coated tablets
Italy: XSYSTO®
Luxembourg: Selexid® 400 mg Comprimés pelliculés
Poland: X-SYSTO® 400 mg Tabletki powlekane
Spain: Selexid® 400 mg Comprimidos recubiertos con película
Germany: X-SYSTO® 400 mg Filmtabletten
Date of last revision of this leaflet: February 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.